CADAMURO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 8.764
AS - Asia 4.520
EU - Europa 1.956
AF - Africa 802
SA - Sud America 722
Continente sconosciuto - Info sul continente non disponibili 141
OC - Oceania 80
Totale 16.985
Nazione #
US - Stati Uniti d'America 8.280
SG - Singapore 1.340
CN - Cina 702
VN - Vietnam 586
HK - Hong Kong 538
IT - Italia 407
BR - Brasile 382
BD - Bangladesh 306
FI - Finlandia 158
DE - Germania 157
FR - Francia 153
IN - India 132
PL - Polonia 126
GB - Regno Unito 89
CA - Canada 86
SE - Svezia 86
NL - Olanda 79
AR - Argentina 75
RU - Federazione Russa 74
IQ - Iraq 69
TR - Turchia 69
JP - Giappone 59
ZA - Sudafrica 56
SA - Arabia Saudita 53
UA - Ucraina 52
PH - Filippine 50
ID - Indonesia 48
MX - Messico 48
PK - Pakistan 47
ES - Italia 43
CL - Cile 40
EC - Ecuador 39
JM - Giamaica 36
NP - Nepal 35
AO - Angola 33
CI - Costa d'Avorio 33
IE - Irlanda 33
MA - Marocco 32
PE - Perù 32
AL - Albania 30
DZ - Algeria 30
GT - Guatemala 30
KE - Kenya 29
MY - Malesia 29
UZ - Uzbekistan 29
AT - Austria 28
CO - Colombia 28
VE - Venezuela 28
GM - Gambi 27
TW - Taiwan 27
UY - Uruguay 27
BY - Bielorussia 25
CR - Costa Rica 25
HN - Honduras 25
PY - Paraguay 25
BA - Bosnia-Erzegovina 24
BO - Bolivia 24
ET - Etiopia 24
MU - Mauritius 24
TN - Tunisia 24
AU - Australia 23
BB - Barbados 23
BJ - Benin 23
HU - Ungheria 23
TH - Thailandia 23
AE - Emirati Arabi Uniti 22
BE - Belgio 22
DO - Repubblica Dominicana 22
GF - Guiana Francese 22
GR - Grecia 22
KR - Corea 22
PA - Panama 22
CU - Cuba 21
CZ - Repubblica Ceca 21
IL - Israele 21
KZ - Kazakistan 21
PT - Portogallo 21
KG - Kirghizistan 20
MK - Macedonia 20
NI - Nicaragua 20
NO - Norvegia 20
PR - Porto Rico 20
RO - Romania 20
SO - Somalia 20
TJ - Tagikistan 20
TZ - Tanzania 20
CH - Svizzera 19
CW - ???statistics.table.value.countryCode.CW??? 19
CY - Cipro 19
EG - Egitto 19
HR - Croazia 19
MD - Moldavia 19
AF - Afghanistan, Repubblica islamica di 18
AZ - Azerbaigian 18
BW - Botswana 18
GH - Ghana 18
IR - Iran 18
LB - Libano 18
MG - Madagascar 18
TL - Timor Orientale 18
Totale 16.037
Città #
Ashburn 1.083
Fairfield 898
Singapore 781
San Jose 733
Woodbridge 641
Hong Kong 491
Houston 487
Chandler 368
Wilmington 341
Cambridge 319
Seattle 319
Santa Clara 296
Ann Arbor 290
Ho Chi Minh City 185
Beijing 157
Los Angeles 146
Hanoi 131
Boardman 126
Princeton 99
Helsinki 98
San Diego 91
Jacksonville 90
Bytom 80
Lauterbourg 78
Medford 78
New York 75
Des Moines 61
Council Bluffs 56
Munich 54
São Paulo 46
Chicago 45
Dallas 45
Buffalo 42
Orem 41
Rome 41
Milan 38
Nanjing 38
Tokyo 35
Da Nang 33
Haiphong 32
London 31
Abidjan 30
Brooklyn 30
Warsaw 27
Baghdad 26
Kingston 26
Atlanta 25
Luanda 25
Montreal 24
Padova 24
Tashkent 24
Bridgetown 23
Dublin 23
Montevideo 22
Nairobi 22
Riyadh 22
Guatemala City 21
Johannesburg 21
Boston 20
Cotonou 20
Guangzhou 20
Naples 20
Nuremberg 20
Panama City 20
San José 20
Managua 19
Tirana 19
Addis Ababa 18
Bishkek 18
Cape Town 18
Dushanbe 18
Havana 18
Hải Dương 18
Lima 18
Roxbury 18
Tampa 18
Antananarivo 17
Baku 17
Dakar 17
Dili 17
Frankfurt am Main 17
Noumea 17
Phoenix 17
Stockholm 17
The Dalles 17
Vienna 17
Willemstad 17
Conakry 16
Denver 16
Djibouti 16
Jinan 16
Kampala 16
Kigali 16
Quito 16
Redondo Beach 16
Rio de Janeiro 16
San Juan 16
Accra 15
Bangkok 15
Belo Horizonte 15
Totale 10.266
Nome #
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis 391
Patogenesi molecolare delle malattie disembriogenetiche dell'epitelio bibliare 351
Platelet-Derived Growth Factor-D Enables Liver Myofibroblasts to Promote Tumor Lymphangiogenesis in Cholangiocarcinoma 341
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma. 337
Benign biliary neoplasms and biliary tumor precursors 302
Olfactory neuroepithelium alterations and cognitive correlates in schizophrenia 301
Analysis of Liver Repair Mechanisms in Alagille Syndrome and Biliary Atresia Reveals a Role for Notch Signaling. 291
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 280
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 277
Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. 277
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 277
ERK1/2-Dependent Vascular Endothelial Growth Factor Signaling Sustains Cyst Growth in Polycystin-2 Defective Mice 264
Animal models of cholestasis: An update on inflammatory cholangiopathies 264
Low dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 257
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma 251
Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies 249
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 237
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development. 232
β-Catenin and interleukin-1β–dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis 229
Animal models of cholangiocarcinoma: What they teach us about the human disease 217
New insights on the role of vascular endothelial growth factor in biliary pathophysiology 211
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 207
Precision medicine in cholangiocarcinoma 205
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice. 204
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 204
Animal models for cystic fibrosis liver disease (CFLD) 204
The patient presenting with isolated hyperbilirubinemia. 203
Necroptosis in Cholangiocarcinoma 203
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 199
Cholangiocarcinoma 197
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 196
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 196
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 193
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 191
Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic 190
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 189
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 189
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 185
Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models 183
Β-CATENIN-MEDIATED CXCL1 AND CXCL10 SECRETION BY FIBROCYSTIN-DEFECTIVE CHOLANGIOCYTES REGULATES PERIBILIARY RECRUITMENT OF FIBROCYTES IN CONGENITAL HEPATIC FIBROSIS 182
Emerging Concepts in Biliary Repair and Fibrosis 182
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 180
Fibrocystic liver disease: Novel concepts and translational perspectives 180
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe-/- atherosclerotic mice 179
A ploidy increase promotes sensitivity of glioma stem cells to aurora kinases inhibition 179
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 178
Diagnostic and prognostic biomarkers in cholangiocarcinoma 175
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1-/- mouse model of congenital hepatic fibrosis 175
LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCARCINOMA CELLS FROM CYTOTOXICITY VIA MCL-1 173
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 172
Cholangiocarcinoma 171
The Neglected Role of Bile Duct Epithelial Cells in NASH 170
Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma 161
Unveiling the Role of Tumor Reactive Stroma in Cholangiocarcinoma: an Opportunity for New Therapeutic Strategies 158
Incretin-based treatment in type 2 diabetes mellitus and risk of cholangiocarcinoma: Is it only adverse drug effect? 156
The emerging role of macrophages in chronic cholangiopathies featuring biliary fibrosis: an attractive therapeutic target for orphan diseases 154
Congenital Cystic Lesions of the Biliary Tree 152
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 150
Liver Matrix in Benign and Malignant Biliary Tract Disease 149
Illuminate TWEAK/Fn14 pathway in intrahepatic cholangiocarcinoma: Another brick in the wall of tumor niche 148
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 147
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 146
The healthy biliary tree: Cellular and immune biology 146
MONOCYTE/MACROPHAGE PERIBILIARY RECRUITMENT BY PKHD1-DEFECTIVE CHOLANGIOCYTES INDUCES EXPRESSION OF aVb6 INTEGRIN ON BILIARY CYSTS VIA TGF-Β1 AND TNF-Α IN CONGENITAL HEPATIC FIBROSIS 144
PKA-DEPENDENT P-SER- 675 β-CATENIN PHOSPHORYLATION INCREASES CHOLANGIOCYTE MOTILITY IN PKHD1DEL4/DEL4 MICE, A MODEL OF FIBROPOLYCYSTIC LIVER DISEASES CAUSED BY DEFECTIVE FIBROCYSTIN FUNCTION 144
Notch signaling and progenitor/ductular reaction in steatohepatitis 143
New case of syncytial giant-cell variant of hepatocellular carcinoma in a pediatric patient with HNF1B deficiency: does it fit with the syndrome? 142
Tumor microenvironment and immunology of cholangiocarcinoma 140
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 139
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 139
MONOCYTE/MACROPHAGE PERIBILIARY RECRUITMENT BY PKHD1-DEFECTIVE CHOLANGIOCYTES INDUCES EXPRESSION OF aVb6 INTEGRIN ON BILIARY CYSTS VIA TGF-Β1 AND TNF-Α IN CONGENITAL HEPATIC FIBROSIS 138
Molecular mechanisms driving cholangiocarcinoma invasiveness: An overview 136
Cholangiocyte biology as relevant to cystic liver diseases 131
Cholangiocyte Biology and Pathobiology 127
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 127
LEUKAEMIA INHIBITORY FACTOR PROTECTS CHOLANGIOCYTES FROM CYTOTOXICITY IN CHOLANGIOCARCINOMA 125
How to mimic a histological sample slide for RNAscope TM applications from BAL cytological specimens 125
PKA dependent p-Ser-675β-catenin, a novel signaling defect in a mouse model of Congenital Hepatic Fibrosis 123
Colestasi intraepatica 118
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 115
Inflammatory pathways and cholangiocarcioma risk mechanisms and prevention 113
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 112
RAC1 AND CDC42 ACTIVATION REGULATES PDGF‐D MEDIATED CAF RECRUITMENT BY CANCER CELLS IN CHOLANGIOCARCINOMA 111
Colangite Sclerosante Primitiva 110
Role of angiogenesis and angiogenetic factors for cholangiocyte growth 110
Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury 106
PKA-DEPENDENT P-SER-675-CATENIN PHOSPHORYLATION INCREASES CHOLANGIOCYTE MOTILITY IN A MOUSE MODEL OF FIBROPOLYCYSTIC LIVER DISEASES 104
Molecular pathogenesis of intrahepatic cholangiocarcinoma: from inflammation and cholestasis to a microenvironment-driven tumor 104
CXCL1 AND CXCL10 SECRETION BY FIBROCISTIDEFECTIVE CHOLANGIOCYTES RECRUITS PERIBILIARY FIBROCYTES IN CONGENITAL HEPATIC FIBROSIS 103
Cirrosi Biliare Primitiva 100
Nephrosphere-Derived Cells Are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 100
Colestasi Genetiche 95
Unmet needs in basic and translational research in Cholangiocarcinoma 82
null 42
Totale 16.985
Categoria #
all - tutte 47.499
article - articoli 42.128
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.548
Totale 94.175


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.137 0 134 145 58 78 69 71 108 118 26 102 228
2022/2023732 170 72 14 93 111 100 2 50 83 2 30 5
2023/2024332 12 59 35 31 21 23 17 12 14 4 40 64
2024/20251.944 9 80 78 73 325 63 99 138 154 78 330 517
2025/20268.867 469 659 1.154 1.349 767 377 1.148 764 853 479 436 412
2026/2027591 318 273 0 0 0 0 0 0 0 0 0 0
Totale 16.985